ALD-201

N/A

Report date: 2022/12/25 13:45:25

Base Information

Drug NameALD-201
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionAngiogenesis inducersStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNuo Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAldagen IncTexas Heart Institute
Inactive CompaniesN/A
Active IndicationsCoronary Artery Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A